All In Biotech

Drug Trial Radar · NCT00690443

Evaluate Safety and Efficacy of AEGR-733 and Atorvastatin vs Atorvastatin Monotherapy in Hypercholesterolemia

A Randomized, Double Blind Comparator-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of the Combination of AEGR-733 and Atorvastatin 20 mg vs Atorvastatin Monotherapy in Subjects With Moderate Hypercholesterolemia

Last checked: Nov 20, 2026Latest source record: Feb 23, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

44

Actual

Start

May 2008

Primary completion

Sep 2008

Study completion Sep 2008

Sponsor

Lead sponsor
Aegerion Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Jun 4, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Evaluate the efficacy of combination therapy AEGR-733 plus atorvastatin 20 mg versus monotherapy on serum lipoproteins over 4 and 8 weeks of therapy. The primary efficacy parameter is percent change in LDL-C after 8 weeks of therapy.

Conditions

  • Hypercholesterolemia

Interventions

  • AtorvastatinDrug

    atorvastatin 20 mg tablets, daily dosing, for 8 weeks.

  • AEGR-733Drug

    2.5 mg AEGR-733 capsules, daily dosing, 4 weeks followed by 5 mg AEGR-733 capsules, daily dosing, 4 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent Change in LDL-C After 8 Weeks of TherapyTime frame: Baseline and 8 weeks of treatment

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Linda Murray, DO - Radiant Research

    Pinellas Park, Florida

  • Sheila Rodstein, MD

    Edina, Minnesota

  • Dennis McCluskey, MD - Radiant Research

    Mogadore, Ohio

  • Michele Reynolds, MD

    Dallas, Texas

  • William Jennings, MD - Radiant Research

    San Antonio, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.